A different cohort with 288 resected NSCLC samples reported PTEN loss in 42.4% (122/288), significantly correlated with SQLC histology, smoking status, advanced disease and larger tumor size, as well as shorter progression-free survival (PFS) than the PTEN positive cases [75]. The gene discussed is PTEN; the disease is neoplasm.